An Open Label Multi-Center Extension Study to Evaluate

Project: Research project

Description

An Open Label Multi-Center Extension Study to Evaluate the Long-term Safety of ZorblisaTM (SD-101-6.0) in Patients with Epidermolysis Bullosa
StatusActive
Effective start/end date4/22/164/30/20

Funding

  • SCIODERM, INC.

Fingerprint

Epidermolysis Bullosa
Safety